[1]
« Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options », Can Hematol Today, vol. 5, nᵒ s01, p. 2–9, févr. 2026, doi: 10.58931/cht.2026.5s0181.